X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MERCK LTD - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE MERCK LTD CADILA HEALTHCARE/
MERCK LTD
 
P/E (TTM) x 34.9 26.6 131.3% View Chart
P/BV x 9.0 3.0 302.1% View Chart
Dividend Yield % 0.7 1.0 71.6%  

Financials

 CADILA HEALTHCARE   MERCK LTD
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
MERCK LTD
Dec-16
CADILA HEALTHCARE/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs4541,060 42.9%   
Low Rs305623 48.9%   
Sales per share (Unadj.) Rs96.1632.4 15.2%  
Earnings per share (Unadj.) Rs14.945.7 32.5%  
Cash flow per share (Unadj.) Rs17.862.3 28.6%  
Dividends per share (Unadj.) Rs3.2011.00 29.1%  
Dividend yield (eoy) %0.81.3 64.5%  
Book value per share (Unadj.) Rs52.3388.8 13.4%  
Shares outstanding (eoy) m1,023.7416.60 6,167.1%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.91.3 296.8%   
Avg P/E ratio x25.518.4 138.6%  
P/CF ratio (eoy) x21.313.5 157.6%  
Price / Book Value ratio x7.32.2 335.4%  
Dividend payout %21.524.1 89.4%   
Avg Mkt Cap Rs m388,45813,969 2,780.9%   
No. of employees `00015.41.6 975.4%   
Total wages/salary Rs m13,3171,487 895.7%   
Avg. sales/employee Rs Th6,371.16,631.9 96.1%   
Avg. wages/employee Rs Th862.4939.2 91.8%   
Avg. net profit/employee Rs Th986.1479.4 205.7%   
INCOME DATA
Net Sales Rs m98,37610,498 937.1%  
Other income Rs m941242 388.2%   
Total revenues Rs m99,31710,741 924.7%   
Gross profit Rs m23,8291,135 2,098.9%  
Depreciation Rs m3,022276 1,096.9%   
Interest Rs m4860-   
Profit before tax Rs m21,2621,102 1,929.1%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,716343 1,665.0%   
Profit after tax Rs m15,226759 2,006.3%  
Gross profit margin %24.210.8 224.0%  
Effective tax rate %26.931.1 86.3%   
Net profit margin %15.57.2 214.1%  
BALANCE SHEET DATA
Current assets Rs m44,3766,410 692.3%   
Current liabilities Rs m34,0718,828 385.9%   
Net working cap to sales %10.5-23.0 -45.5%  
Current ratio x1.30.7 179.4%  
Inventory Days Days5458 93.4%  
Debtors Days Days6238 162.4%  
Net fixed assets Rs m47,8961,406 3,405.6%   
Share capital Rs m1,024166 616.9%   
"Free" reserves Rs m48,7466,286 775.5%   
Net worth Rs m53,5196,455 829.2%   
Long term debt Rs m8,9640-   
Total assets Rs m100,1638,828 1,134.6%  
Interest coverage x44.7NM-  
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.2 82.6%   
Return on assets %15.78.6 182.5%  
Return on equity %28.411.8 242.0%  
Return on capital %34.317.1 200.8%  
Exports to sales %45.38.3 546.7%   
Imports to sales %5.921.0 28.2%   
Exports (fob) Rs m44,537869 5,122.7%   
Imports (cif) Rs m5,8382,209 264.3%   
Fx inflow Rs m44,881959 4,681.0%   
Fx outflow Rs m9,0692,612 347.2%   
Net fx Rs m35,812-1,653 -2,166.2%   
CASH FLOW
From Operations Rs m19,9381,070 1,862.7%  
From Investments Rs m-9,039-750 1,205.7%  
From Financial Activity Rs m-9,527-150 6,359.8%  
Net Cashflow Rs m1,372171 802.8%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 8.3 18.2 45.6%  
FIIs % 5.9 1.0 590.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 29.1 37.8%  
Shareholders   44,069 28,591 154.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NOVARTIS  TORRENT PHARMA  FRESENIUS KABI ONCO.  CIPLA  ABBOTT INDIA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS